Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Parathyroid Hormone for the Treatment of Hypoparathyroidism

NCT00856401 is registered in ClinicalTrials.gov with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor.

NCT NCT00856401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00856401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Parathyroid Hormone for the Treatment of Hypoparathyroidism
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase
Phase 3
Overall status
Unknown status
Start date
September 30, 2010
Completion date
June 30, 2021
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoparathyroidism